Statistics
Publications
2
Citations
20
H-Index
2
Active since
2005
Affiliations
Jeffrey Calimlim is an author at University of California, Los Angeles specializing in immunotherapy, bortezomib therapy, and pharmacology.
Publications per year
2005–2006
2
2
Bortezomib Is a Novel Inducer of Latent Epstein Barr Virus (EBV) in EBV+ Lymphoma Cell Lines.
Vesna Kaluza, Helen Braun, Jeffrey Calimlim et al. · Blood · 2006 · 10 citations
1–2 of 2